Big Pharma's Alzheimer's gold rush: 35 new drugs to hit the market in the next few years as the drug cartels cash in on cognitive decline

(Natural News) It’s no big secret that the pharmaceutical industry isn’t at all concerned with trying to advance the cause of improving public health by identifying the causes of age-related cognitive decline. But it sure is banking on raking in a windfall of profits trying to treating it, with the latest figures showing that pharmaceutical…

View original article
Author:

Powered by WPeMatico